Immune checkpoint inhibitors in extensive-stage small cell lung cancer
-
Published:2022-09
Issue:3
Volume:2
Page:130-131
-
ISSN:2667-0054
-
Container-title:Journal of the National Cancer Center
-
language:en
-
Short-container-title:Journal of the National Cancer Center
Reference8 articles.
1. Small-cell lung cancer;Rudin;Nat Rev Dis Primers,2021
2. A Plan of Attack for Deadly Cancers;Cancer Discov,2014
3. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial;Paz-Ares;Lancet,2019
4. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer;Horn;N Engl J Med,2018
5. Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial;Wang;Lancet Oncol,2022
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献